GEODE CAPITAL MANAGEMENT, LLC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 87 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$972,371
-26.6%
94,405
+17.4%
0.00%
Q2 2023$1,325,024
+80.8%
80,402
+0.5%
0.00%
Q1 2023$732,827
+129374.7%
80,003
+1.2%
0.00%
Q4 2022$566
-99.7%
79,079
+95.1%
0.00%
Q3 2022$203,000
+107.1%
40,5280.0%0.00%
Q2 2022$98,000
-64.5%
40,5280.0%0.00%
Q1 2022$276,000
-15.6%
40,5280.0%0.00%
Q4 2021$327,000
-17.6%
40,5280.0%0.00%
Q3 2021$397,000
+46.0%
40,5280.0%0.00%
Q2 2021$272,000
-29.0%
40,528
-4.5%
0.00%
Q1 2021$383,000
+66.5%
42,445
+22.8%
0.00%
Q4 2020$230,000
+32.2%
34,5520.0%0.00%
Q3 2020$174,000
-21.3%
34,552
+26.1%
0.00%
Q2 2020$221,000
+6.8%
27,395
+4.9%
0.00%
Q1 2020$207,000
-70.3%
26,113
-71.8%
0.00%
Q4 2019$696,000
+262.5%
92,440
+100.0%
0.00%
Q3 2019$192,000
+44.4%
46,2200.0%0.00%
Q2 2019$133,000
+150.9%
46,220
+24.9%
0.00%
Q1 2019$53,000
-72.1%
36,999
-50.0%
0.00%
Q4 2018$190,000
+17.3%
73,998
+100.0%
0.00%
Q3 2018$162,000
-28.3%
36,9990.0%0.00%
Q2 2018$226,000
+145.7%
36,999
+191.8%
0.00%
Q1 2018$92,000
-10.7%
12,6800.0%0.00%
Q4 2017$103,000
-55.4%
12,680
-42.5%
0.00%
Q3 2017$231,000
-37.1%
22,052
-33.8%
0.00%
Q2 2017$367,000
+21.5%
33,326
+6.6%
0.00%
Q1 2017$302,00031,2630.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 985,210$10,345,0006.10%
Broadfin Capital, LLC 3,568,122$37,465,0005.54%
JW Asset Management, LLC 444,439$4,667,0003.42%
ARMISTICE CAPITAL, LLC 1,688,000$17,724,0002.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$38,383,0001.73%
FALCON POINT CAPITAL, LLC 661,490$6,284,0000.91%
KNOTT DAVID M 158,555$1,665,0000.71%
Perceptive Advisors 3,098,010$32,530,0000.62%
Sio Capital Management, LLC 91,413$960,0000.50%
HEARTLAND ADVISORS INC 700,000$7,350,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders